Search Results 1831-1840 of 4073 for Solid

1. Hematology - Clinical trials

   Trimethoprim-sulfamethoxazole Graded Administration in Oncology, Hematopoietic Stem Cell Transplant, and Solid Organ Transplant Patients with a History of ...

2. Infectious Diseases - Clinical trials

   ... Solid Organ Transplantation. Jacksonville, Fla. The purpose of this study is to determine the safety of the SARS-CoV-2 vaccination in patients listed for solid ...

3. A Study to Evaluate Ipilimumab Administered Intra-lymphatically Using the Sofusa® DoseConnect™ DEVICE with IV-administered Nivolumab in Patients with Metastatic Melanoma - Mayo Clinic

   Solid organ transplantation. Co-morbid systemic illnesses or other severe concurrent disease which, in the judgment of the investigator, would make the ...

4. Brightline-1: A Study to Compare Bi 907828 With Doxorubicin In People With a Type of Cancer Called Dedifferentiated Liposarcoma - Mayo Clinic

   retrospective histopathological central review. - Presence of at least one measurable target lesion according to Response Evaluation Criteria In Solid Tumors ( ...

5. Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer - Mayo Clinic

   Prior allogeneic bone marrow transplantation or prior solid organ transplantation; Treatment with systemic immunosuppressive medications (including but not ...

6. Vitamin B-12 injections for weight loss: Do they work? - Mayo Clinic

   There's no solid proof that vitamin B-12 shots, also called injections, help you lose weight. Vitamin B-12 is a water-soluble B complex vitamin. It's found ...

7. Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma - Mayo Clinic

   No prior allogeneic stem cell or solid organ transplantation. Central nervous system (CNS) metastases must have been treated with local therapy (surgery ...

8. Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Participants With a Kirsten Rat Sarcoma Virus Gene (KRAS) or Neuroblastoma-RAS (NRAS) Mutation - Mayo Clinic

   Only participants with measurable disease as defined per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v1.1) are eligible for enrollment.

9. Ivosidenib, Nivolumab, and Ipilimumab Combination in Previously Treated Subjects with Nonresectable or Metastatic IDH1-Mutant Cholangiocarcinoma - Mayo Clinic

   ... solid or liquid tumor within 2 years prior (i.e., participants with a history of prior malignancy are eligible if treatment was completed at least 2 years ...

10. Efineptakin alfa (NT-I7) Plus Pembrolizumab for the Treatment of Recurrent Glioblastoma - Mayo Clinic

    * History of allogenic tissue/solid organ transplant. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 10/21 ...